Pharmabid, LLC
Pharmabid, LLC, a prominent player in the pharmaceutical industry, is headquartered in the United States and operates across key regions globally. Founded in 2015, the company has rapidly established itself as a leader in pharmaceutical procurement and supply chain solutions, catering to a diverse clientele that includes healthcare providers and pharmaceutical manufacturers. Specialising in innovative bidding platforms, Pharmabid offers unique services that streamline the procurement process, ensuring efficiency and cost-effectiveness. The company’s commitment to transparency and competitive pricing has positioned it favourably within the market, earning recognition for its robust technology and customer-centric approach. With a focus on enhancing accessibility to essential medications, Pharmabid continues to make significant strides in the healthcare landscape.
DitchCarbon Score
How does Pharmabid, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmabid, LLC's score of 3 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pharmabid, LLC's reported carbon emissions
Pharmabid, LLC, headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures for the most recent year. Consequently, there are no recorded emissions in terms of Scope 1, 2, or 3. Additionally, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. As there is no available data or commitments, Pharmabid, LLC's climate strategy remains unclear within the context of industry standards. The absence of emissions reporting and reduction initiatives may reflect a broader trend in the pharmaceutical sector, where companies are increasingly being urged to disclose their environmental impact and set ambitious climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharmabid, LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
